mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.06 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.07 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.098 |
0.07 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.07 |